IL2RB and COVID-19: Notably, also EBV- and IAV-specific CD8+ T cells showed increased CD25 and CD122 during acute COVID-19, which was still present at 6 M follow-up and only returned to healthy levels at 12 M follow-up (Fig. 4d).